Wanlin Zhang
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Enhanced rhLCV production in lymphoblastoid cell lines derived from rhLCV-infected cynomolgus macaque PBMCs.
Journal: Journal of virology
Published: January 27, 2026
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk.
Journal: Nature
Published: July 14, 2025
TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice.
Journal: Emerging microbes & infections
Published: October 10, 2024
Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics.
Journal: Viruses
Published: March 24, 2024
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection.
Journal: Nature communications
Published: September 20, 2023
Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes.
Journal: Emerging microbes & infections
Published: August 05, 2023
High-density lipoprotein cholesterol modifies the association between blood lead and uric acid: results from NHANES 2005-2016.
Journal: International archives of occupational and environmental health
Published: September 20, 2022
Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection.
Journal: Cell reports. Medicine
Published: September 13, 2022
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 02, 2022
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus.
Journal: Virology journal
Published: July 26, 2022
Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells.
Journal: Frontiers in immunology
Published: April 14, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.
Journal: Journal of virology
Published: March 29, 2022
Last Updated: 09/26/2026